KyungDong Pharm home
Prescription Medicines

VitaBsix Inj.

Product Category
Vitamin B6 injection
Active Ingredients
Pyridoxine hydrochloride
Appearance
Colorless to light yellow transparent injection solution contained in a brown transparent ampoule.
View Regulatory Information on the MFDS Portal ↗
1. Composition and Strength
Of 1ml
- Active ingredient: Pyridoxine hydrochloride (KP) 50mg
- Additives: Water for injection

2. Effectiveness
1. Prevention and treatment of vitamin B6 deficiency
Includes cases caused by drug administration (e.g. isoniazid, hydralazine, pyrazinamide, penicillamine)
2. As the demand for vitamin B6 increases, when intake from meals is insufficient, it can be caused by wasting diseases, pregnant or lactating women, those taking estrogen preparations (e.g. oral contraceptives), etc.
3. Vitamin B6 dependence
Vitamin B6 reactive anemia, etc.
4. Cases where vitamin B6 deficiency or metabolic disorders are presumed to be involved in any of the following diseases:
1) Angular cheilitis, cheilitis, stomatitis, glossitis
2) Acute/chronic eczema, seborrheic eczema, contact dermatitis
3) Peripheral neuritis
4) Radiation disorders (hangover, hangover)

3. Dosage and dosage
When oral administration is difficult
○ Adults: Pyridoxine hydrochloride, 10 to 100 mg per day divided into 1 to 2 divided doses and injected intramuscularly, subcutaneously or intravenously.
- In case of vitamin B6 dependence, high doses can be administered.
Increase or decrease appropriately depending on age and symptoms.

4. Precautions for use
1. Warning
Ampoule injections may be mixed with glass fragments when cutting the container, which may cause adverse reactions. When using, cut carefully to minimize glass fragments, but be especially careful when using them on children and the elderly.

2. Do not administer to the following patients.
1) Patients with hypersensitivity to this drug or its ingredients
2) Patients receiving levodopa

3. Adverse reactions
1) Photosensitivity reaction, nausea, headache, and drowsiness may occur.
2) If taken in high doses for a long period of time (taking more than 2 g per day over several months), nerve spasms, paralysis of hands and feet, and sensory neurosis accompanied by ataxia may occur. If you stop taking the drug, symptoms will improve, but it may take about 6 months to return to normal.
3) Discomfort and pain may occur during injection.
4) If used in large quantities in newborns and infants, rhabdomyolysis, which is an increase in creatine kinase (CK, CPK) and an increase in myoglobin in the blood and urine, may occur, and serious kidney disorders such as acute renal failure may occur. Therefore, observe sufficiently and immediately stop administration if abnormalities are recognized.

4. Generalism
1) Caution should be exercised when pregnant women take high doses as it has been reported to be associated with vitamin B6 dependence syndrome in newborns and infants.
2) When administering high doses for vitamin B6 dependence, sufficient observation is required.
In particular, when administering to newborns and infants, start from a small amount and gradually increase the dose to reach an amount appropriate for the symptoms.
3) Temporary dependence may occur after high-dose administration, so it is necessary to gradually reduce the dose and discontinue it.

5. Interaction
1) This drug should not be administered together as it may increase the peripheral metabolism of levodopa and reduce its effectiveness.
2) Isoniazid, penicillamine, and estrogen preparations (e.g. oral contraceptives) increase the requirement for vitamin B6.
3) As a result of administering altretamine and cisplatin in combination with pyridoxine to ovarian cancer patients, pyridoxine significantly reduced neurotoxicity, but it had an adverse effect on the response period (reduction in response period), so do not administer this drug in combination with altretamine and cisplatin.

6. Administration to pregnant and lactating women
It has been reported that high doses taken by pregnant women are associated with vitamin B6 dependence syndrome in newborns and infants.

7. Administration to children
If used in large quantities in newborns and infants, rhabdomyolysis, diarrhea, vomiting, and liver function abnormalities may occur, so administer with caution.

8. Storage and handling precautions
1) Keep out of reach of children.
2) Avoid direct sunlight and, if possible, keep tightly closed in a cool, low-humidity place.
3) Taking medicine out of its original container and storing it in another container may cause an accident due to misuse of the medicine or cause a decrease in the quality of the medicine, so put it in the original container and keep it tightly closed.

5. How to save
Light-proof sealed container, stored at room temperature (1∼30℃)

6. Packaging unit
1mL

7. Validity period
36 months from date of manufacture